The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?

End-to-end support in Bourgoin: From preclinical phases to commercial production

Video

Our Bourgoin, France, oral solid dose (OSD) facility is equipped with cutting-edge technologies to develop and manufacture a wide range of drug products, including highly potent APIs. Our end-to-end capabilities allow us to handle quantities from grams for preclinical phases to hundreds of kilograms for clinical studies and commercial production.

Additionally, the expertise of Thermo Fisher Scientific’s onsite staff enables our customers to navigate complex scientific and technical challenges throughout the development and manufacturing lifecycle. With advanced equipment and comprehensive services, we support the evolving demands of small molecule pharmaceutical development.

Watch as Pascal Taillardat, technical operations manager, discusses the range of services available at our Bourgoin, France, facility.

See more:

Video
CDMO excellence at Bourgoin: Advancing OSD drug development
Watch as Isabelle Lafosse-Marin, general manager of our Bourgoin site, discusses our oral drug delivery capabilities—including integrated development, manufacturing, and packaging services.
Advantages of Localized Oral Solid Dose Production in Europe
Discover how partnering with a localized OSD production facility in Europe can offer advantages, including regulatory expertise and supply chain stability.